Arch Therapeutics : Schedule filed to report acquisition of beneficial ownership of 5% or more of a ...

Retrieved on: 2021-01-22 22:30:00

Tags for this article:

Click the tags to see associated articles and topics

Arch Therapeutics : Schedule filed to report acquisition of beneficial ownership of 5% or more of a .... View article details on hiswai:

Excerpt

Arch Therapeutics, Inc. (Name of Issuer). Common Stock, par value $0.001 per share. (Title of Class of Securities). 003939W 109. (CUSIP Number).

Article found on: www.marketscreener.com